701 related articles for article (PubMed ID: 29483826)
1. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
[TBL] [Abstract][Full Text] [Related]
2. Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway.
Han B; Sheng B; Zhang Z; Pu A; Yin J; Wang Q; Yang K; Sun L; Yu M; Qiu Y; Xiao W; Yang H
Shock; 2016 Sep; 46(3):319-28. PubMed ID: 26939041
[TBL] [Abstract][Full Text] [Related]
3. 6-Formylindolo(3,2-b)carbazole induced aryl hydrocarbon receptor activation prevents intestinal barrier dysfunction through regulation of claudin-2 expression.
Ma Y; Wang Q; Yu K; Fan X; Xiao W; Cai Y; Xu P; Yu M; Yang H
Chem Biol Interact; 2018 May; 288():83-90. PubMed ID: 29680209
[TBL] [Abstract][Full Text] [Related]
4. Spermidine protects intestinal mucosal barrier function in mice colitis via the AhR/Nrf2 and AhR/STAT3 signaling pathways.
Yan B; Mao X; Hu S; Wang S; Liu X; Sun J
Int Immunopharmacol; 2023 Jun; 119():110166. PubMed ID: 37104918
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1 dependent signaling pathway.
Liu Z; Li L; Chen W; Wang Q; Xiao W; Ma Y; Sheng B; Li X; Sun L; Yu M; Yang H
Int J Mol Med; 2018 Mar; 41(3):1560-1572. PubMed ID: 29286081
[TBL] [Abstract][Full Text] [Related]
6. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.
Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR
Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185
[TBL] [Abstract][Full Text] [Related]
8. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
[TBL] [Abstract][Full Text] [Related]
9. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
[TBL] [Abstract][Full Text] [Related]
10. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
Cao M; Wang P; Sun C; He W; Wang F
PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
[TBL] [Abstract][Full Text] [Related]
12. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
Ye X; Sun M
Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
[TBL] [Abstract][Full Text] [Related]
13. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction.
Liu H; Li M; Wang P; Wang F
Cytokine; 2011 Dec; 56(3):581-8. PubMed ID: 21890376
[TBL] [Abstract][Full Text] [Related]
14. Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation.
Yu M; Yang S; Qiu Y; Chen G; Wang W; Xu C; Cai W; Sun L; Xiao W; Yang H
J Gastroenterol; 2015 Nov; 50(11):1103-13. PubMed ID: 25820151
[TBL] [Abstract][Full Text] [Related]
15. Pterostilbene Ameliorates DSS-Induced Intestinal Epithelial Barrier Loss in Mice via Suppression of the NF-κB-Mediated MLCK-MLC Signaling Pathway.
Wang J; Zhao H; Lv K; Zhao W; Zhang N; Yang F; Wen X; Jiang X; Tian J; Liu X; Ho CT; Li S
J Agric Food Chem; 2021 Apr; 69(13):3871-3878. PubMed ID: 33759516
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases.
Tao Y; Yue M; Lv C; Yun X; Qiao S; Fang Y; Wei Z; Xia Y; Dai Y
FASEB J; 2020 Feb; 34(2):3069-3090. PubMed ID: 31908053
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers.
Chen SW; Zhu J; Zuo S; Zhang JL; Chen ZY; Chen GW; Wang X; Pan YS; Liu YC; Wang PY
Inflamm Res; 2015 Oct; 64(10):789-97. PubMed ID: 26249853
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis.
Li X; Li Q; Xiong B; Chen H; Wang X; Zhang D
Pharmacol Res; 2022 Sep; 183():106368. PubMed ID: 35905891
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model.
Dinallo V; Marafini I; Di Fusco D; Di Grazia A; Laudisi F; Dwairi R; Paoluzi OA; Monteleone G; Monteleone I
Front Immunol; 2019; 10():91. PubMed ID: 30778350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
